A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

Clinical trial NCT06661915 · RECRUITING

Trial details

NCT number: NCT06661915
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Accelerated Phase Myeloproliferative Neoplasm Blast Phase Myeloproliferative Neoplasm Essential Thrombocythemia Myelodysplastic/Myeloproliferative Neoplasm Myeloproliferative Neoplasm, Not Otherwise Specified Polycythemia Vera Primary Myelofibrosis Secondary Myelofibrosis

Start date: 2025-08-14
Primary completion: 2027-12-31
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.